St. Jude Cloud Survivorship Portal offers a treasure trove of data for discovery in childhood cancers

Posted by Karishma Gangwani, PhD | Dec 19, 2023

Childhood cancer survivors are a unique population that can be challenging to study – but the survivorship portal on St. Jude Cloud is making data more accessible for research.

Learn more

Shared Resource Spotlight: The Good Manufacturing Practice (GMP) Facility

Posted by Jessica Gullett-Rubino, PhD | Dec 12, 2023

Learn more about how the St. Jude Good Manufacturing Practice facility is manufacturing lifesaving therapeutics for children with cancer and catastrophic diseases

Learn more

Molecular diagnostics bring treatment opportunities to infants with brain tumors

Posted by Kathryn J. McCullough, MA | Oct 26, 2023

Research in integrated, molecular diagnostics gave Fletcher Fazenbaker’s family something they thought they’d never get — a diagnosis and treatment plan.

Learn more

Collaborating for Care: Developing a New Global Standard for Sickle Cell Disease Treatment

Posted by Taylor Wewel | Sep 28, 2023

Discover how St. Jude researchers are influencing sickle cell disease treatment globally.

Learn more

SJiMB21: A molecular path to treating infants with medulloblastoma

Posted by Kathryn J. McCullough, MA, and Jessie Newman | May 18, 2023

At St. Jude, clinical trial SJiMB21 seeks to provide treatment strategies for infants and young children diagnosed with medulloblastoma that place the patient, not just the tumor, at the center of care.

Learn more

Research adds to understanding of AYA patients

Posted by Kerry Hillis Goff | Apr 6, 2023

Psychological, social and behavioral research sheds light on the needs of adolescents and young adults with cancer.

Learn more

Diagnostic Imaging receives hospital’s first Expanded Access use designation from FDA

Posted by Matt Gaschk | Dec 29, 2022

St. Jude received the hospital’s first expanded access designation from the FDA for use of PET scans with [11C]Methionine a tracer that makes imaging results clearer.

Learn more

St. Jude advice to young adults with sickle cell disease: Stay connected

Posted by Mary Powers | Nov 28, 2022

The St. Jude Methodist Sickle Cell Disease Transition Clinic helps patients move from pediatric to adult care, an important stage where patients often experience roadblocks to maintaining their health.

Learn more

Studies of rare craniopharyngioma reveal ways to improve long-term outcomes for patients

Posted by Erin Podolak, MA | Nov 15, 2022

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

Learn more

Latin American hospitals implement tool to identify kids whose condition is deteriorating

Posted by Mary Powers | Nov 1, 2022

Flexible and tailored implementation strategies helped pediatric cancer centers across Latin America scale up a proven quality improvement strategy.

Learn more